Driving Clinical Results with Allogeneic & Solid Tumor Innate Therapies

Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8^th Innate Killer Summit returned to cement your end-to-end education in innate immune therapeutics. Your industry-defining Innate Killer Summit bought crucial insights for everyone on your team, spanning preclinical development, clinical translation, CMC, process development, and clinical scale manufacturing, this was the definitive meeting to drive concept to commercial success of emerging innate immune therapies.

Download your copy of the 2023 Full Event Guide here.

Join over 250 experts from 120+ pioneering companies to drive novel gene engineering technologies, gain regulatory know-how, optimize lymphodepletion and cryopreservation, and contrast cell sources for highly efficacious, scalable off-the-shelf therapies.

Promising brand-new speakers from new companies, interactive discussion, and engaging networking opportunities join the 8th Innate Killer Summit to forge new collaborations and realize the clinical potential of innate immune therapies.